The judge assigned to handle the Yaz Lawsuit, Multi District Litigation, often referred to as the Yaz Class Action Lawsuit, has granted more time to Bayer, the maker of Yaz and the plaintiff law firms representing over 11,000 claimants, to settle the case before a trail begins.

New Yaz Lawsuits are still being filed. Given that there was no official recognition of the relationship between Yaz and blood clot related medical problems until 2011, the time limit to file Yaz Lawsuits has not expired. Women who took Yaz and suffered blood clot related problems such as strokes, deep vein thrombosis, pulmonary embolisms.

Although the United States Food and Drug Administration did not officially announce the problems associated with Yaz until 2011, numerous lawsuits had already been filed. The issue with Yaz that has led to the massive number of lawsuits being filed stems from one of the ingredients in Yaz, drospirenone. For more information on Yaz Lawsuits or to arrange a consultation with a Yaz Lawyer contact Best Legal Source at (800) 611-7080

Individuals with an interest in filing a mesothelioma lawsuit Iowa or hiring a mesothelioma attorney Iowa should know that the statute of limitations for personal injury law in Iowa is two years with a discovery rule declaring that this amount of time begins when the problem was discovered or should have been discovered. Wrongful death cases fall under the same statute of limitations and follow the same discovery rule. However, Iowa’s Supreme Court has adopted a “separate injury rule” that allows plaintiffs to file mesothelioma lawsuits Iowa for asbestos cancer regardless of whether the victim had developed asbestosis at a much earlier date.

Under this rule, the discovery of asbestosis does not trigger the statute of limitations on asbestos-related diseases that develop later, including cancers such as mesothelioma, allowing victims of such cancers to hire an Iowa mesothelioma lawyer and pursue compensation for their disease. This means that mesothelioma victims in Iowa who have discovered the disease after having first developed asbestosis can seek a mesothelioma settlement Iowa within the statute of limitations related to the discovery date of the cancer.

In another 2007 case, students at one Iowa elementary school had their classes relocated as officials discovered that the glue on asbestos-containing ceiling tiles was failing, causing tiles to fall. This again points to the fact that despite lack of those seeking mesothelioma settlements Iowa, there are reasons for continued concern by Iowa’s citizens. In fact, four mesothelioma victims and their mesothelioma lawyers Iowa have come together in 2007 in a lawsuit against a Des Moines company that manufactures putty used for wood and plaster repairs, model building and sculpting. This is only the second asbestos-related lawsuit for the company, which has made putty since 1932. The first case against the company was dismissed in 2005 when tests conducted on behalf of the plaintiff failed to find asbestos.

What is mesothelioma? It is a lethal cancer that attacks the membranes around the lungs, the heart and the abdominal cavity. mesothelioma cancer of the lungs is by far the most common form. Perhaps its most unusual characteristic is that mesothelioma diagnosis usually occurs decades after the initial exposure to asbestosis.

It takes years for the asbestosis fibers to work their way into those membranes. After an extended presence, they begin to cause fluid accumulation and tumor development. However, the first mesothelioma symptoms are such afflictions as a persistent cough or shortness of breath – symptoms that are often mistaken for evidence of more common lung problems, which delays the mesothelioma diagnosis even further.

The result of this lengthy disease development and diagnosis process is that malignant mesothelioma is nearly always well developed.

Many mesothelioma patients face a poor prognosis and limited treatment options.

Asbestos exposure has been linked to a number of life-threatening diseases, including lung cancer and mesothelioma. Asbestos exposure is also known to cause a non-cancerous disease called asbestosis, which involves scarring of the lung tissue. Most asbestos exposure related illnesses stem from the inhalation of asbestos fibers. Individuals breathe in asbestos particles during asbestos exposure and the fibers become trapped in lung tissue.

Some asbestos-related illnesses do not manifest symptoms until many years later, even decades after initial asbestos exposure. However, some people develop serious ailments within a few months of asbestos exposure.

The length of asbestos exposure also correlates to the severity of the illness, with those patients who had long-term asbestos exposure usually experiencing more acute forms of the disease than individuals whose asbestos exposure lasted only a few months.

If you or someone you love has developed an asbestos-related condition due to asbestos exposure, you may be entitled to seek compensation for your damages through an asbestos lawsuit.

In general, most stage I mesothelioma and a small number of patients in stage II and III are considered resectable. Although not all early-stage cancers are removable, when the disease has been detected near the beginning of its evolution, the chances of successful surgery are much better. Patients whose cancer is diagnosed and treated for stage I usually show longer term benefits, including the possibility of long remissions.

By contrast, patients’ tumors in stage IV mesothelioma cannot be totally eliminated due to the spread of cancer. Stage IV mesothelioma does not respond to treatments. Instead, doctors often recommend palliative treatments to reduce cancer growth and relieve pain and other symptoms associated.

When deciding to operate on a malignant mesothelioma, an oncologist will also take into account their size and subtype. Many doctors say that tumors composed of epithelioid cells are resectable, while sarcomatoid and biphasic cells do not respond to the procedure. If the tumor has spread to other parts of the body, surgery usually is not recommended.

If resection is approved, the procedure will be determined by the location of the tumor. Pleural mesothelioma is often treated with pleurectomy or extrapleural pneumonectomy. A pleurectomy removes some of the lining of the lungs. The last option removes an entire lung and is often used in patients with pleural mesothelioma whose cancer is restricted to a single lung.

The pathology is intended to remove all or part of a mesothelioma tumor, but in cases where this procedure poses more risks than benefits, chemotherapy and radiation can be chosen instead of an operation. These treatments may also be used to monitor a successful surgery when the patient can tolerate a more aggressive approach in the fight against cancer.

Because mesothelioma can take years, or even decades to emerge after initial asbestos exposure, mesothelioma cases pose unique challenges. Over such long periods of time, the companies who manufactured and sold asbestos may go out of business, interchange their names or go into the production of different products. They may move their headquarters to other states or even other countries. Often, they have been acquired by other corporations and are operated as subsidiaries.

This can make it difficult for the mesothelioma attorney to identify the party who bears ultimate responsibility for exposing a victim to asbestos in the first place. Typically, preparing for an asbestos case requires large amounts of detailed research such as the examination of old records, previous cases, legal documents and even photographs. Often, witnesses must be found and asked for testimony regarding events and issues dating back 20 to 40 years or more.

In addition, because the potential onset of mesothelioma is often years after exposure to asbestos, establishing that the disease was caused by exposure in a specific location during a specific timeframe often requires the testimony of medical experts.

A mesothelioma attorney must master the many complexities associated with an asbestos exposure case. In many instances, it is important to identify not only where asbestos exposure took place and under what conditions, but also who the original manufacturer of the substance or product in question was years after the exposure took place. Many of these manufacturers were acquired by and merged with other corporations; therefore a parent company under a different name may be held liable. As of 2000, Halliburton, for example, had paid out nearly $100 million to settle multiple asbestos suits against its subsidiaries.

Mesothelioma is a malignant cancerous disease of the cells lining the patient’s body cavities such as chest, abdominal region or the area surrounding the heart. It is thought to be associated with exposure to asbestos, and this asbestos association has been documented in 70-80 percent of all mesothelioma cases. Asbestos cancer or mesothelioma is very difficult to assess and diagnose consistently. The time between exposure, the onset of the disease and the rate of progressionmake diagnosis very difficult.

It is believed that even inconspicuous exposure to asbestos in environments such as asbestos mills, mines, shipping yards, some older Navy ships or even patient’s homes can result in mesothelioma. In many cases, mesothelioma does not occur for decades after initial exposure to this cancer-causing asbestos. Two thousand to three thousand cases of mesothelioma per year are currently being diagnosed. Family members of workers exposed to asbestos can also contract this disease through exposure to the worker’s clothing. Like many other cancers, smoking greatly multiplies the risk of contracting mesothelioma.

Some of the earliest symptoms of mesothelioma are commonly overlooked because of similarity to symptoms of less dangerous diseases. Some patients do not show any signs of sickness in the early stages of development of the disease. The most common symptoms of mesothelioma include dyspnoea, pleuritic pain, lasting cough, fatigue and weight loss. These symptoms cannot be attributed to mesothelioma unless the patient is examined by a competent and knowledgeable health care provider who orders the appropriate tests. Tests for mesothelioma or asbestos cancer may include CT scans, x-rays scans, or an MRI. Surgery can be one of the treatment options; however, the recurrence rate of cancerous cells is high. It is very significant that the disease is diagnosed and treated as early as possible.

This disease is not more prevalent in any particular race or ethnic group; however, it is more common in men. Most cases of mesothelioma occur 30-45 years after initial exposure to asbestos. Once it develops, this cancer will continue to grow until it is treated or the victim dies.

Malignant mesothelioma is the most serious of all asbestos-related diseases. Virtually all cases of malignant mesothelioma are attributable to asbestos exposure. If you have mesothelioma or you know someone who has been diagnosed with mesothelioma, remember that time matters. The sooner you consult your doctor and get professional care, the better your chances will be of dealing with this dangerous asbestos cancer.

In the January 18 separate rulings, the U.S. District Court for the Southern District of West Virginia noted that the issue of a prior settlement release is pending in a Kentucky state court, in which two wrongful death asbestos actions have been filed.

The first claims were confirmed on behalf of Willie Collins, who was allegedly exposed to asbestos and other toxic substances while working as a laborer, oiler and blacksmith. As a result of his exposure, Collins developed asbestosis. He subsequently filed a claim against CSX under the Federal Employers Liability Act. The parties later reached a settlement agreement that totaled $20,000 and Collins signed a release of related future tort claims against CSX.

After the settlement, Collins was diagnosed with lung cancer. After his death, his surviving family members filed another against CSX, this time in Kentucky, contending that the defendant violated FELA and the Locomotive Boiler Inspect Act. In CSX’s answer to the complaint, it attached a copy of the release.In September, however, CSX filed the instant declaratory action, seeking a ruling from the court that the provisions in the settlement release barred the Kentucky action. The Collins family filed a motion to dismiss, citing the lack of subject matter and personal jurisdiction.

The federal court, however, found that it did in fact have subject matter jurisdiction, since CSX has demonstrated that the amount in controversy would exceed $75,000.The court additionally found that since Collins had originally filed his lawsuit in West Virginia, he purposefully availed himself of West Virginia law and, as such, the court had personal jurisdiction over the claims.

“The Court finds that the decedent purposefully availed himself of the benefits and protections of West Virginia law for purposes of this action because he chose to initiate a FELA occupational lung claim in Mason County, and because he signed a release and indemnification agreement in West Virginia as part of the settlement of that claim,” the court said.

After determining that it did in fact have jurisdiction over the declaratory action, the West Virginia District Court turned to the analysis of whether the action could proceed, noting Collins’ request that the proceedings be stayed, pending the outcome of the Kentucky action.The district court ultimately concluded that the Kentucky court is “entirely capable of determining the validity of the [settlement] clause and whether it bars the defendant’s FELA claims.”

“Maintaining this action would cause unneeded entanglement between the federal and state court systems in light of the noted overlapping issues of law and fact,” the court said. “As the issue of release has already been presented to the Kentucky court, a decision from this Court on the defendant’s indemnity obligations to CSX for defending against claims purportedly barred by the settlement agreement would cause conclusion and potentially conflicting results. At best, CSX’s request for indemnification is premature until the Kentucky court determines the validity of the release clause.”

Before 1998, mesothelioma deaths were organized only as part of a group of asbestos cancers. Early death certificates only classified deaths by the location of the cancer instead of the cell types that composed a tumor. Mesothelioma cases were recorded only as cancers of the pleura or peritoneum. The coding used to report deaths to statistics agencies only indicated the site of occurrence. When the government assigned codes to mesothelioma in 1999, the death rates nearly doubled.

With 935 mesothelioma deaths in 1998 and 2,343 noted in 1999, the CDC began to investigate the dramatic rise. After reviewing the certificates of patients with pleural and peritoneal cancer, the CDC recalculated the log files, creating a new proportion of deaths from asbestos total estimated mesothelioma. This more accurately reflects the number of deaths that resulted from exposure to asbestos before the coding change in 1999.

Mesothelioma is now using code identifying malignancy in the lining of organs that may be affected. This helps differentiate between mesothelioma, which affects only the membrane around certain organs, and other cancers that attack the organs. The pleural mesothelioma is coded as ICD-9 code 163, peritoneal mesothelioma is classified as ICD-9 code 158 and pericardial mesothelioma is known as ICD-9 code 164

The PHLBI operates in a “capacity to pay” basis and seeks to provide quality care to all patients regardless of their income. Dr. Cameron, the specialist for PHLBI, has developed a single system to preserve the lungs that has been used for over 20 years. His methodology to mesothelioma treatment, used on over 300 patients to date, addresses the cancer as an incurable chronic disease.

He is the innovator of a multimodal approach that uses a combination of surgery, radiation therapy and long-term maintenance to prevent recurrences. Cameron maintains that no procedure can completely eliminate all mesothelioma cells from a patient and pleurectomy/decortications leaves the lung intact and does less damage to the patient’s body.

Mesoamerican Pacific Center has been named the primary beneficiary of an upcoming fundraiser organized by the Dana Point Community Foundation Cycling Dana Point, California. This event features food, drinks and a silent auction with a portion of the proceeds going to research for mesothelioma. Amgen Breakaway from Cancer Grand Prix fundraiser is scheduled to be held on Saturday, April 30, 2011.

Funds received from the fundraiser will go to new PHLBI current studies of mesothelioma, including various immunotherapy projects. They are conducted at treatment centers across the country and shed light on the results of the immune system’s inhibitory effect on tumor cells.

Although evidence suggests that a strong immune system may help fight mesothelioma, researchers are trying to confirm the correlations and develop procedures to capitalize on this knowledge.